SFX by Ex Libris Inc.

Title:	Severe Combined Immunodeficiency Mice Engrafted With Human T Cells, B Cells, and Myeloid Cells After Transplantation With Human Fetal Bone Marrow or Liver Cells and Implanted With Human Fetal Thymus: A Model for Studying Human Gene Therapy
Source:	Blood [0006-4971] Yurasov, Sergey yr:1997

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Calvo, M. "Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease." Science 288.5466 (2000): 669-672.
description	2.	Hacein-Bey-Abina, S. "LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1." Science 302.5644 (2003): 415-9.
description	3.	Hacein-Bey-Abina, S. "A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency." New England Journal of Medicine, The 348.3 (2002): 255-6.
description	4.	Cavazzana-Calvo, M. "Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1." The journal of clinical investigation 118.9 (2008): 3132-42.
description	5.	Hacein-Bey-Abina, S. "Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy." New England Journal of Medicine, The 346.16 (2002): 1185-1193.
description	6.	Buckley, R H H. "Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency." The New England journal of medicine 340.7: 508-16.
description	7.	Baum, C. "Chance or necessity? Insertional mutagenesis in gene therapy and its consequences." Molecular therapy 9.1 (2004): 5-13.
description	8.	Rabbitts, Terence H H. "Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency." The New England journal of medicine 350.9 (2004): 913-22.
description	9.	White, K. "Novel vectors for in vivo gene delivery to vascular tissue." Expert Opinion on Biological Therapy 7.6 (2007): 809-821.
description	10.	Cartier, N. "Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy." Science 326.5954 (2009): 818-823.
description	11.	Patel, D. "Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency." New England Journal of Medicine, The 342.18 (2000): 1325-1332.
description	12.	Fischer, A. "20 years of gene therapy for SCID." Nature Immunology 11.6 (2010): 457-460.
description	13.	Periasamy, M. "SERCA2a gene therapy for heart failure: Ready for primetime?" Molecular therapy 16.6 (2008): 1002-1004.
description	14.	Howe, S. "Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients." The journal of clinical investigation 118.9 (2008): 3143-50.
description	15.	Fischer, A. "Gene therapy of severe combined immunodeficiencies." Nature reviews. Immunology 2.8 (2002): 615-621.
description	16.	Verma, I M M. "Gene therapy -- promises, problems and prospects." Nature 389.6648 (1997): 239-42.
description	17.	Viele, M R. "Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation." Bone marrow transplantation 24.9 (1999): 1009-1013.
description	18.	Borghans, José A A. "Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency." Blood 108.2 (2006): 763-769.
description	19.	Cavazzana-Calvo, M. "Gene therapy for severe combined immunodeficiency: are we there yet?" The journal of clinical investigation 117.6 (2007): 1456-65.
description	20.	High, K. "Gene therapy: the moving finger." Nature 435.7042: 577-579.